$PROV

Leaving Estimates in the Dust: 28 Firms Beating Earnings Expectations

Morgan Stanley research cited by the article says the median S&P 500 EPS surprise was 6% in Q1 2026, above the long-run ~5.5% average. FactSet research cited says firms with positive EPS surprises tend to keep outperforming after results. The article lists 28 companies that beat Wall Street EPS expectations, including Ford (EPS $0.66 vs $0.31), Bloom Energy (EPS $0.78 vs $0.37; revenue >$1B, +164% YoY), and Incyte (EPS $3.09 vs $0.94).

Original reporting
Published Jul 29, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 10:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Leaving Estimates in the Dust: 28 Firms Beating Earnings Expectations — source image
Decision brief

The 30-second read

$PROVBullishLow
01

Why it matters

It suggests that companies with positive EPS surprises tend to outperform after reporting, and then enumerates 28 stocks that beat Wall Street expectations on or around the current earnings season.

02

Market read

Traders can use the list as a starting point for screening post-earnings drift, but the article itself does not provide new guidance or deeper fundamentals for most names.

03

What to watch

The article omits revenue, margins, cash flow, and forward guidance for most names, so traders may need to verify whether beats were sustainable or due to temporary factors.

Relevance 4/10Novelty 3/10Timing: during the current earnings season, after July 28’s wave of reports

Background

The piece frames earnings outperformance using Morgan Stanley and FactSet research on median EPS surprises and post-earnings announcement drift.

Company-level read

Ticker impact

$PROVBullishMedium confidence
Context

Provident Financial Holdings reported Q2 EPS of $0.35, beating estimates by $0.07, making it one of the 28 named “beat” stocks.

Expected impact

Mild positive bias over the next several weeks versus peers that missed, absent other new disclosures.

Evidence & confidence

The article provides a specific EPS beat magnitude but no guidance, revisions, or qualitative drivers.

$RCKYBullishLow confidence
Context

Rocky Brands posted EPS of $1.90, topping expectations by $1.55, placing it in the article’s list of earnings beatters.

Expected impact

Potential short-to-medium-term upside drift relative to the market on the beat alone.

Evidence & confidence

No revenue, margin, or forward guidance details are provided, limiting conviction.

$QUADBullishLow confidence
Context

Quad/Graphics reported EPS of $0.24, beating analyst targets by $0.04, per the article’s “28 firms” list.

Expected impact

Slight positive drift possible, but likely limited magnitude.

Evidence & confidence

Beat size is small and the article lacks additional fundamental specifics.

$XIFRBullishLow confidence
Context

XPLR Infrastructure surprised with EPS of $0.40, beating expectations by $0.90, according to the article.

Expected impact

Higher probability of near-term positive reaction and drift versus smaller-beat names.

Evidence & confidence

No context on revenue quality or guidance is included.

$NEOBullishLow confidence
Context

NeoGenomics reported Q2 EPS of $0.05, topping estimates by $0.02, as one of the 28 beat stocks.

Expected impact

Neutral-to-mild positive drift possible.

Evidence & confidence

The article provides only EPS beat figures, not drivers or outlook.

$CTSBullishLow confidence
Context

CTS Corporation posted $0.74 EPS in the second quarter, beating estimates by $0.13, per the list.

Expected impact

Mild positive bias over subsequent trading sessions.

Evidence & confidence

No additional disclosures beyond the EPS beat are provided.

$PIIBullishLow confidence
Context

Polaris reported EPS of $1.97, topping expectations by $1.26, included among the 28 earnings beatters.

Expected impact

Potential for stronger drift than average beat names.

Evidence & confidence

The article omits revenue, margins, and guidance details.

$MIRBullishLow confidence
Context

Mirion Technologies posted EPS of $0.12, beating expectations by $0.02, according to the article.

Expected impact

Limited upside drift likely, given small beat magnitude.

Evidence & confidence

No forward-looking or qualitative drivers are disclosed.

Market effects

Broad-based earnings beats across many industries may support a constructive earnings-season risk tone, but the article provides no sector-specific drivers.

Primarily US-listed equities; no cross-region policy or macro shock is disclosed.

No direct global macro or international deal/regulatory catalyst is provided beyond general earnings-season framing.

Counterpoint

A list of EPS beats without guidance or qualitative drivers can overstate tradability; post-earnings drift may fade if beats are driven by one-offs.

Key entities

  • S&P 500 companies (median EPS surprise)

    Morgan Stanley research cited median EPS surprise reaching 6% in Q1 2026, strongest in four years.

  • FactSet post-earnings drift

    FactSet research cited average share-price gains after positive EPS surprises.

  • 28 listed companies

    The article enumerates 28 US-listed firms with reported EPS beats and specific beat amounts.

Related articles

$GEVMedAI 8/10

GE Vernova vs. Bloom Energy: Which AI-Power Bet Has More Upside Ahead?

GE Vernova (GEV) and Bloom Energy (BE) are positioned to benefit from AI's power demands. GEV raised 2026 revenue guidance to $45.5B-$46.5B, with power division orders up 134% and electrification orders at $6.3B. Bloom reported $1B+ revenue and $196.2M net profit in Q2 2026. GEV has broader operations and a $176B backlog, while BE's stock is up 150% in 2026.

$GEVHighAI 9/10

GE Vernova vs. Bloom Energy: Which AI

GE Vernova (GEV) raised 2026 revenue guidance to $45.5B-$46.5B, driven by strong AI-related power division demand. Bloom Energy (BE) reported Q2 2026 revenue over $1B and net profit of $196.2M. GEV's power and electrification divisions saw significant order growth, while Bloom's stock is up 150% in 2026. GEV's broader operations and backlog of $176B are noted as advantages.

$NEOHighAI 8/10

Biotech Stocks At 52-Week Highs - NEO, BLSM, RVMD, ORMP, CADL

NeoGenomics (NEO), BlossomHill Therapeutics (BLSM), Revolution Medicines (RVMD), Oramed Pharmaceuticals (ORMP), and Candel Therapeutics (CADL) reached 52-week highs on August 27, 2026. NEO reported Q2 revenue growth of 11% and a profit turnaround. BLSM began trading on Nasdaq and received FDA Fast Track designation. RVMD's lead drug, Rasonque, was FDA-approved. ORMP's net income increased significantly. CADL reported a higher net loss but plans a BLA filing for its lead drug.

$FMed

ZEV mandate consultation: van sector reaction

The UK government is reviewing its Zero Emission Vehicle (ZEV) mandate, which requires van manufacturers to meet rising annual targets for zero-emission van sales, reaching 100% by 2035. The consultation, running until October 2026, follows industry concerns over market demand and compliance costs. Companies like Ford and Stellantis support the mandate but seek adjustments to reflect current market conditions. The review aims to balance the transition to electric vehicles with economic sustainab